Egypt Generic Drugs Market, Small Molecule Generics to dominate through 2028
Egypt
Generic Drugs Market is driven by the growing prevalence of diseases in Egypt
during the forecast period, 2024-2028.
According to
TechSci Research report, “Egypt Generic Drugs Market- Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028”, Egypt Generic
Drugs Market to grow at an impressive rate through 2028. This can be ascribed
to the strong manufacturing capabilities of Egypt. Additionally, Egypt has a
lower cost of manufacturing compared to many other countries, which makes it an
attractive location for generic drug manufacturers. This allows companies to
produce high-quality generic drugs at a lower cost, which benefits patients by
making medications more affordable, thereby driving the growth of Egypt generic
drugs markets. Furthermore, Egypt has a skilled workforce in the pharmaceutical
industry, with many workers trained in the production of generic drugs. This
allows local manufacturers to produce high-quality medications that meet
international standards thereby supporting the growth of Egypt generic drugs
market. Besides, many Egyptian generic drug manufacturers have formed
partnerships with international companies to develop and manufacture generic
drugs. These partnerships allow local manufacturers to benefit from
international expertise, while also expanding their reach in the global market.
This in turn is expected to support the growth of Egypt generic drugs market in
the coming years.
There is a
growing emphasis on the quality and safety of generic drugs in Egypt.
Regulatory agencies are increasing their oversight of the industry, and
manufacturers are investing in quality assurance systems to ensure that their
products meet international standards. This in turn will make room for Egyptian
manufactured generic drugs not only in the domestic market but also overseas,
thereby opening new prospects for the overall growth of Egypt generic drugs
market. Also, there is a growing interest in the development and manufacturing
of biopharmaceuticals in Egypt, which are used to treat a range of diseases,
including cancer and autoimmune disorders. This is a relatively new area for
the local industry, but there is significant potential for growth in this
market segment. The use of digital technology, such as telemedicine and
e-pharmacies, is increasing in Egypt. This is creating new opportunities for
the distribution and sale of generic drugs, as well as improving patient access
to healthcare services.
However,
competition of imported products can hamper the growth of Egypt generic drugs
market. The Egyptian government has made efforts to encourage local
manufacturing of generic drugs, imported drugs continue to be popular due to
perceptions of higher quality and reliability. Also, many small and
medium-sized generic drug manufacturers in Egypt face limited access to
financing, which can make it difficult for them to invest in research and
development and expand their operations, thereby slowing down the growth of
Egypt generic drugs market.
Browse over
XX market data Figures spread through XX Pages and an in-depth TOC on the
"Egypt Generic Drugs Market”
Egypt Generic
Drugs market is segmented into type, application, drug delivery, form, source,
distribution channel, region, and company. In terms of drug delivery, Egypt
Generic Drugs Market can be divided into oral, topical, parenteral, and others.
The oral route dominated the Egypt generic drugs market in 2022 owing to the
various benefits associated with oral route of drug delivery such as
convenience, self and pain free administration, among others. Additionally,
oral route of drug delivery is regarded as the simplest and safest means of
drug administration.
By form, Egypt
Generic Drugs Market can be fragmented into tablet, capsule, injection, and
others. The tablet segment dominated the Egypt Generic Drugs market in 2022 and
will continue maintaining its dominance through 2028 on account of the fact
that they can accommodate a higher dose of active ingredient than other
counterparts. Additionally, tablets have longer shelf life and are available in
variety of forms.
Major
companies operating in the Egypt Generic Drugs Market are:
- Eva Pharma
- Pharco Pharmaceuticals
- Amoun Pharmaceutical Company S.A.E.
(“Amoun”)
- Rameda Pharmaceutical Company
- Delta Pharmaceutical Industries
- Global Napi Pharmaceuticals (Global
Pharmaceutical Group)
- Minapharm Pharmaceuticals Co.
- Adwia Pharmaceuticals Co.
- GlaxoSmithKline S.A.E
- Sanofi Egypt
- Hikma Pharmaceuticals Plc
- Egyptian International
Pharmaceutical Industries (EIPICO)
- Medical Union Pharmaceuticals
- MDI Pharma
- AstraZeneca Egypt
Download
Sample Report
Customers can
also request for 10% free customization on this report.
“In Egypt,
generic drugs are widely available and play a significant role in the country's
healthcare system. The government encourages the use of generic drugs to
provide affordable and accessible healthcare to all citizens. This has led to
an increase in the availability and use of generic drugs in the country,
thereby driving the growth of Egypt generic drugs market. The Egypt generic
drugs market is highly competitive, with several local and international
companies operating in the space. In addition to the domestic market, Egypt is
also an exporter of generic drugs. The country exports to several countries in
the Middle East and Africa, with Saudi Arabia and Sudan being the largest markets.”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based global management consulting firm.
Egypt
Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By
Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology,
Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical,
Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source
(In House v/s Contract Manufacturing Organizations), By Distribution Channel
(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) By Region,
Competition, Forecast & Opportunities, 2028F, has evaluated the future growth
potential of Egypt Generic Drugs Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and opportunities
in Egypt Generic Drugs Market.”
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com